986例肝硬化患者病因及临床特点分析

肝脏 ›› 2022, Vol. 27 ›› Issue (8): 871-873.

986例肝硬化患者病因及临床特点分析

佟印妮, 郑吉敏, 韩丹, 江萍, 王存凯, 王玉珍, 白云

050051 石家庄河北省人民医院消化科(佟印妮,郑吉敏,江萍,王存凯,王玉珍,白云);黑龙江省第二医院皮肤科(韩丹)

收稿日期:2021-10-19 出版日期:2022-08-31 发布日期:2022-09-30
通讯作者: 郑吉敏,Email:jmzheng205@sohu.com
基金资助:
河北省2019年度医学科学研究课题(20190260)

Analysis of etiology and clinical characteristics in 986 patients with liver cirrhosis

TONG Yin-ni¹, ZHENG Ji-min¹, HAN Dan², JIANG Ping¹, WANG Cun-kai¹, WANG Yu-zhen¹, BAI Yun¹

1. Department of Gastroenterology, Hebei General Hospital, Shijiazhuang 050051, China;
2. Department of Dermatology, The Second Hospital of Heilongjiang Province, Haerbin 150010, China

Received:2021-10-19 Online:2022-08-31 Published:2022-09-30
Contact: ZHENG Ji-min, Email: jmzheng205@sohu.com

摘要/Abstract

摘要： 目的分析近5年首次住院的肝硬化患者的病因分布及临床特点。方法回顾性分析2016年1月至2020年12月于河北省人民医院首次确诊为肝硬化患者的临床资料,分析其病因分布情况及血浆D-二聚体水平在肝硬化的不同肝功能状态、有无腹水、是否合并自发性细菌性腹膜炎(SBP)中的差别。结果 986例肝硬化患者中乙型肝炎患者431例、酒精性肝病146例、隐源性肝病124例。血浆D-二聚体水平在肝功能Child-pughC级、B级、A级分别为2.71、1.36、0.41 mg/L,差异有统计学意义(P<0.05)。腹水组血浆D-二聚体的中位数为2.16 mg/L,无腹水组为0.49 mg/L(P<0.05);腹水SBP组D-二聚体的中位数为4.52 mg/L,腹水非SBP组1.98 mg/L(P<0.05)。结论肝硬化的主要病因仍为乙型肝炎病毒感染。D-二聚体水平与肝功能损伤的严重程度密切相关,若D-二聚体水平明显升高应警惕腹水及SBP的发生。

关键词: 肝硬化, 病因, D-二聚体

Abstract: Objective To investigate the etiology and clinical characteristics of patients with liver cirrhosis with first hospitalization in recent 5 years. And to prevent, diagnose and treat liver cirrhosis based on etiology, as well as improve the survival rates.Methods The clinical data of patients with liver cirrhosis admitted to our hospital from January 2016 to December 2020 were retrospectively analyzed. The distribution of causes was recorded. The clinical data of plasma D-dimer levels in different liver functional status of cirrhosis, ascites, and spontaneous bacterial peritonitis (SBP) were collected. And the clinical significances were analyzed.Results Among the 986 patients with liver cirrhosis, 431 complicated with hepatitis B virus (HBV) infection, 146 complicated with alcoholic liver disease and 124 complicated with cryptogenic liver disease. There were significant differences in plasma D-dimer levels among different Child-pugh classification, (Child-pugh score C > B >A, P<0.05). The median of plasma D-dimer in ascites group and non-ascites group were 2.16 mg/L and 0.49 mg/L, respectively (P<0.05); The median of D-dimer in ascites SBP groupand non-ascites group were 4.52 mg/L and 1.98mg/L, respectively (P<0.05).Conclusion The main cause of liver cirrhosis is still HBV infection. The D-dimer level of patients with liver cirrhosis is closely related to the severity of liver function injury. If the level of D-dimer is significantly increased, ascites and SBP should be paid more attention to.

Key words: Liver cirrhosis, Etiology, D-dimer

佟印妮, 郑吉敏, 韩丹, 江萍, 王存凯, 王玉珍, 白云. 986例肝硬化患者病因及临床特点分析[J]. 肝脏, 2022, 27(8): 871-873.

TONG Yin-ni, ZHENG Ji-min, HAN Dan, JIANG Ping, WANG Cun-kai, WANG Yu-zhen, BAI Yun. Analysis of etiology and clinical characteristics in 986 patients with liver cirrhosis[J]. Chinese Hepatolgy, 2022, 27(8): 871-873.

参考文献

[1] 中华医学会肝病学分会. 肝硬化诊治指南. 现代医药卫生,2020,36(2):320, 插1-插18.
[2] 沈自雄,李敏,张嵴明,等. 兰州地区肝硬化的病因构成及临床特征分析. 临床肝胆病杂志,2020,36(04):783-787.
[3] 郑银城,韩超,李艳伟,等. 2012年与2017年3065例肝硬化病因及其并发症对比分析. 中国实用内科杂志,2019,39(03):278-281.
[4] 章燕虹,李游,陈龙,等. 2890例住院的肝硬化患者病因和并发症分析. 实用肝脏病杂志,2018,21(03):344-347.
[5] 王晓霞,邹正升,李保森,等. 2002至2011年中国“北方”地区住院肝硬化患者病因构成及变化趋势分析. 实用肝脏病杂志,2014,17(02):154-158.
[6] 张维兰,罗和生. 湖北地区肝硬化病因及相关分析. 胃肠病学和肝病学杂志,2019,28(03):325-329.
[7] 张艳婷,杨少奇,王鵷臻,等. 宁夏回族自治区肝硬化病因分析. 中华传染病杂志,2014,32(05):299-300.
[8] Schwinge D, Schramm C. Sex-related factors in autoimmune liver diseases. Semin Immunopathol,2019,41(2):165-175.
[9] Dai R, Ahmed S A. Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases. Ther Clin Risk Manag,2014,10:151-163.
[10] Li B, Zhang C, Zhan Y T. Nonalcoholic fatty liver disease cirrhosis: a review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis. Can J Gastroenterol Hepatol,2018,2018:2784537.
[11] Zhou J, Mao W, Shen L, et al. Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis. Medicine (Baltimore),2019,98(52):e18527.
[12] Weitz J I, Fredenburgh J C, Eikelboom J W. A test in context: D-dimer. J Am Coll Cardiol,2017,70(19):2411-2420.
[13] Saray A, Mesihovic R, Gornjakovic S, et al. Association between high D-dimer plasma levels and ascites in patients with liver cirrhosis. Med Arch,2012,66(6):372-374.
[14] Li Y, Qi X, Li H, et al. D-dimer level for predicting the in-hospital mortality in liver cirrhosis: a retrospective study. Exp Ther Med,2017,13(1):285-289.
[15] Violi F, Ferro D, Basili S, et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology,1995,109(2):531-539.
[16] Agarwal S, Joyner K J, Swaim M W. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol,2000,95(11):3218-3224.
[17] Piscaglia F, Donati G, Giannini R, et al. Liver cirrhosis, ascites, and hyperfibrinolysis. Am J Gastroenterol,2001,96(11):3222.